Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis

Journal of Clinical Investigation

Volumn 113, Issue 9, 2004, Pages 1318-1327

  Jia, Song Hui ^a,b   Li, Yue ^c   Parodo, Jean ^b   Kapus, Andras ^a,b   Fan, Lingzhi ^b   Holstein, Ori D ^a,b   Marshall, John C ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; CASPASE; PRE B CELL COLONY ENHANCING FACTOR, HUMAN; PRE-B-CELL COLONY-ENHANCING FACTOR, HUMAN;

APOPTOSIS; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATION; KINETICS; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSLATION; SEPSIS; SIGNAL TRANSDUCTION; ANIMAL; BLOOD; CELL CULTURE; CELL STRAIN HL 60; CHO CELL; COMPARATIVE STUDY; CRICETULUS; CULTURE MEDIUM; DRUG EFFECT; GENE EXPRESSION REGULATION; HAMSTER; IMMUNOLOGY; METABOLISM; MONOCYTE; PATHOLOGY; PHYSIOLOGY; TIME;

ANIMALS; APOPTOSIS; CASPASES; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; CULTURE MEDIA; CYTOKINES; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HL-60 CELLS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; KINETICS; LIPOPOLYSACCHARIDES; MONOCYTES; NEUTROPHILS; OLIGONUCLEOTIDES, ANTISENSE; RECOMBINANT FUSION PROTEINS; SEPSIS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85047693796     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI19930     Document Type: Article

References (67)

1. Riedemann, N.C., Guo, R.-F., and Ward, P.A. 2003. The enigma of sepsis. J. Clin. Invest. 112:460-467. doi:10.1172/JCI200319523.
2. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature. 420:885-891.
3. Angus, D.C., et al. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303-1310.
4. Bone, R.C., et al. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 101:1644-1655.
5. Lekstrom-Himes, J.A., and Gallin, J.I. 2000. Immunodeficiency diseases caused by defects in phagocytes. N. Engl. J. Med. 343:1703-1714.
6. Beutler, B., and Poltorak, A. 2001. Sepsis and evolution of the innate immune response. Crit. Care Med. 29(Suppl.):S2-S7.
7. Marie, C., et al. 1997. Presence of high levels of leukocyte-associated interleukin-8 upon cell activation and in patients with sepsis syndrome. Infect. Immun. 65:865-871.
8. Gautam, N., et al. 2001. Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability. Nat. Med. 7:1123-1127.
9. Lee, W.L., and Downey, G.P. 2001. Leukocyte elastase. Physiological functions and role in acute lung injury. Am. J. Resp. Crit. Care Med. 164:896-904.
10. Ho, J.S., Buchweitz, J.P., Roth, R.A., and Ganey, P.E. 1996. Identification of factors from rat neutrophils responsible for cytotoxicity to isolated hepatocytes. J. Leukoc. Biol. 59:716-724.
11. Kubes, P., Hunter, J., and Granger, D.N. 1992. Ischemia/reperfusion induced feline intestinal dysfunction: importance of granulocyte recruitment. Gastroenterology. 103:807-812.
12. Lauriat, S., and Linas, S.L. 1998. The role of neutrophils in acute renal failure. Semin. Nephrol. 18:498-504.
13. Weiss, S.J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320:365-376.
14. Smith, J.A. 1994. Neutrophils, host defense, and inflammation: a double-edged sword. J. Leukoc. Biol. 56:672-686.
15. Savill, J.S., Wyllie, A.H., Henson, J.E., Henson, P.M., and Haslett, C. 1989. Macrophage phagocytosis of aging neutrophils in inflammation. J. Clin. Invest. 83:865-875.
16. Lee, A., Whyte, M.K.B., and Haslett, C. 1993. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukoc. Biol. 54:283-288.
17. Jimenez, M.F., et al. 1997. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome (SIRS). Arch. Surg. 132:1263-1270.
18. Keel, M., et al. 1997. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood. 90:3356-3363.
19. Matute-Bello, G., et al. 2000. Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome. Crit. Care Med. 28:1-7.
20. Watson, R.W.G., Rotstein, O.D., Parodo, J., Bitar, R., and Marshall, J.C. 1998. The interleukin-1 beta converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1β. J. Immunol. 161:957-962.
21. Diatchenko, L., et al. 1996. Suppressive subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl. Acad. Sci. U. S. A. 93:6025-6030.
22. Samal, B., et al. 1994. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol. Cell. Biol. 14:1431-1437.
23. Fujiki, K., Shin, D.-H., Nakao, M., and Yano, T. 2000. Molecular cloning and expression analysis of the putative carp (Cyprinus carpio) pre-B cell enhancing factor. Fish Shellfish Immunol. 10:383-385.
24. Muller, W.E., et al. 1999. Increased gene expression of a cytokine-related molecule and profilin after activation of Suberites domuncula cells with xenogeneic sponge molecule(s). DNA Cell Biol. 18:885-893.
25. Martin, P.R., Shea, R.J., and Mulks, M.H. 2001. Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence. J. Bacteriol. 183:1168-1174.
26. Ognjanovic, S., and Bryant-Greenwood, G.D. 2002. Pre-B cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am. J. Obstet. Gynecol. 187:1051-1058.
27. Rongvaux, A., et al. 2002. Pre-B cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur. J. Immunol. 32:3225-3234.
28. Kitani, T., Okuno, S., and Fujisawa, H. 2003. Growth phase-dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor. FEBS Lett. 544:74-78.
29. Marshall, J.C., Jia, S.-H., and Taneja, R. 2002. Dysregulated neutrophil apoptosis in the pathogenesis of organ injury in critical illness. In Mechanisms of organ dysfunction in critical illness. M.P. Fink and T.W. Evans, editors. Springer-Verlag. Berlin, Germany. 110-123.
30. Rotstein, D., Parodo, J., Taneja, R., and Marshall, J.C. 2000. Phagocytosis of Candida albicans induces apoptosis of human neutrophils. Shock. 14:278-283.
31. Bennett, C.F., Chiang, M.Y., Chan, H., Shoemaker, J.E., and Mirabelli, C.K. 1992. Cationic lipids enhance cellular uptake and activity of phosphorothirate antisense oligonucleotides. Mol. Pharmacol. 41:1023-1033.
32. Sabroe, I., Jones, E.G., Usher, L.R., Whyte, M.K., and Dower, S.K. 2002. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J. Immunol. 168:4701-4710.
33. Thornberry, N.A., and Lazebnik, Y.A. 1998. Caspases: enemies within. Science. 281:1312-1316.
34. Hengartner, M.O. 2000. The biochemistry of apoptosis. Nature. 407:770-776.
35. Chinnaiyan, A.M., O'Rourke, K., Tewari, M., and Dixit, V.M. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:505-512.
36. Susin, S.A., et al. 1999. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J. Exp. Med. 189:381-393.
37. Enati, M., et al. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:43-50.
38. Knaus, W.A., Draper, E.A., Wagner, D.P., and Zimmerman, J.E. 1985. APACHE II: a severity of disease classification system. Crit. Care Med. 13:818-829.
39. Marshall, J.C., et al. 1995. Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit. Care Med. 23:1638-1652.
40. Ognjanovic, S., et al. 2001. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J. Mol. Endocrinol. 26:107-117.
41. Nemeth, E., Millar, L.K., and Bryant-Greenwood, G. 2002. Fetal membrane distention: II. Differentially expressed genes regulated by acute distention in vitro. Am. J. Obstet. Gynecol. 182:60-67.
42. Tang, H., Cheung, W.M., Ip, F.C., and Ip, N.Y. 2000. Identification and characterization of differentially expressed genes in denervated muscle. Mol. Cell. Neurosci. 16:127-140.
43. van Beijnum, J.R., et al. 2002. Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer. Int. J. Cancer 101:118-127.
44. Subrahmanyam, Y.V.B.K., et al. 2001. RNA expression patterns change dramatically in human neutrophils exposed to bacteria. Blood. 97:2457-2468.
45. Nau, G.J., et al. 2002. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. U. S. A. 99:1503-1508.
46. Xu, L.-G., Wu, M., Hu, J., Zhai, Z., and Shu, H.-B. 2002. Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1. J. Leukoc. Biol. 72:410-416.
47. Wang, H., et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:248-251.
48. Park, J.S., et al. 2003. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol. 284:C870-C879.
49. Brezniceanu, M.L., et al. 2003. HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma. FASEB J. 17:1295-1297.
50. Irmler, M., et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature. 388:190-195.
51. Daigle, I., Yousefi, S., Colonna, M., Green, D.R., and Simon, H.-U. 2002. Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils. Nat. Med. 8:61-67.
52. Gardai, S., et al. 2002. Activation of SHIP by NADPH oxidase-stimulated Lyn leads to enhanced apoptosis in neutrophils. J. Biol. Chem. 277:5236-5246.
53. Savill, J. 1997. Apoptosis in resolution of inflammation. J. Leukoc. Biol. 61:375-380.
54. Savill, J., and Fadok, V. 2000. Corpse clearance defines the meaning of cell death. Nature. 407:784-788.
55. Lee, A., Whyte, M.K.B., and Haslett, C. 1993. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukoc. Biol. 54:283-288.
56. Watson, R.W.G., Redmond, H.P., Wang, J.H., Condron, C., and Bouchier-Hays, D. 1996. Neutrophils undergo apoptosis following ingestion of Escherichia coli. J. Immunol. 156:3986-3992.
57. Nicholson, D.W. 2000. From bench to clinic with apoptosis-based therapeutic agents. Nature. 407:810-816.
58. Marshall, J.C. 2003. Such stuff as dreams are made on: mediator-targeted therapy in sepsis. Nat. Rev. Drug Discov. 2:391-405.
59. Bernard, G.R., et al. 2001. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344:699-709.
60. Reed, J.C. 2002. Apoptosis-based therapies. Nat. Rev. Drug Discov. 1:111-121.
61. Marshall, J.C., and Sweeney, D. 1990. Microbial infection and the septic response in critical surgical illness. Sepsis, not infection, determines outcome. Arch. Surg. 125:17-23.
62. Watson, R.W.G., et al. 1997. Granulocytic differentiation of HL-60 cells results in expression of caspase-dependent programmed cell death. FEBS Lett. 412:603-606.
63. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F., and Riccardi, C. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:271-276.
64. Homburg, C.H., et al. 1995. Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood. 85:532-540.
65. Bustin, S.A. 2000. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25:169-193.
66. Johnson, M.R., Wang, K., Smith, J.B., Heslin, M.J., and Diasio, R.B. 2000. Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. Anal. Biochem. 278:175-184.
67. Aida, Y., and Pabst, M.J. 1990. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J. Immunol. Methods. 132:191-195.